A liquid biopsy comprehensive genomic profiling research assay
Benefits of the PGDx liquid biopsy CGP research assay
PGDx elio plasma complete is a liquid biopsy CGP assay that puts cutting-edge plasma based technology in the hands of scientists researching tumor biomarkers directly from blood samples. This easy-to-use tumor profiling tool offers the flexibility of a liquid biopsy format to the global research community in a way never seen before. Automatically curated reports highlight a wide array of high-impact current and emerging biomarkers, simplifying the task of sifting through data.
Requires low input for high coverage
A single blood draw is all you need for a high coverage next-generation sequencing panel of 521 genes
Liquid biopsy format
Provides researchers with flexibility as they identify new biomarkers and develop insights
Highly accurate somatic mutation identification
Including SNVs, indels, bTMB, MSI, LOH, and select amplifications and translocations
Distributed
Gene panel with SNVs, indels, bTMB, MSI, LOH and select amplifications and translocations
Day* turnaround time from isolated nucleic acid to variant report
Concordance with comparator NGS and PCR-based methods
Sequencing coverage
Nanograms of input volume required
* Kitted workflow plus pipeline output. Not inclusive of DNA extraction and downstream processing.
PGDx elio™ plasma complete bioinformatics rapidly and accurately identifies cancer mutations, empowering every lab with timely and trustworthy results. High quality training data, expert curation and machine learning algorithms combine to provide best-in-class identification of cancer mutations.
PGDx elio plasma complete is an end-to-end kitted liquid biopsy research solution that analyzes circulating tumor DNA for genomic alterations in cancer. Designed to be used across the globe, PGDx elio plasma complete is powered by automated bioinformatics ensuring consistent, high-quality results, no matter where you’re located. Get the technical specifications:
Patent Disclaimer
For Research Use Only.
Personal Genome Diagnostics Inc. (PGDx) is a subsidiary of Laboratory Corporation of America Holdings, using the brand Labcorp.
©2024 Laboratory Corporation of America® Holdings. All rights reserved.